Cargando…
Interluekin-35 in Asthma and Its Potential as an Effective Therapeutic Agent
Interleukin- (IL-) 35 is a member of the IL-12 cytokine family and a heterodimeric protein formed by Epstein-Barr-induced gene 3 (EBI3) and IL-12p35. Emerging evidence shows that IL-35 is a key player in the regulation of cellular communication, differentiation, and inflammation. Altered IL-35 expre...
Autores principales: | Gao, Peng, Su, Zhenzhong, Lv, Xuejiao, Zhang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434467/ https://www.ncbi.nlm.nih.gov/pubmed/28553015 http://dx.doi.org/10.1155/2017/5931865 |
Ejemplares similares
-
The potential of interleukin-37 as an effective therapeutic agent in asthma
por: Zhang, Lina, et al.
Publicado: (2017) -
Interleukin-32: its role in asthma and potential as a therapeutic agent
por: Xin, Tong, et al.
Publicado: (2018) -
Periostin: its role in asthma and its potential as a diagnostic or therapeutic target
por: Li, Wei, et al.
Publicado: (2015) -
The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 Expression
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2021) -
Genetic association between interluekin-4 rs2243250 polymorphism and gastric cancer susceptibility: evidence based on a meta-analysis
por: Zhang, Chi, et al.
Publicado: (2016)